Topics
Gliomas | Treatment | Immunotherapy | CAR-T-Cells
Home > Publications > Topics > Gliomas > Treatment > Immunotherapy > CAR-T-Cells
Song KW, Scott BJ.
CAR T-cell therapy
for gliomas.
Curr
Opin Neurol. 2024 Oct 9;37(6):672-681. doi:
10.1097/WCO.0000000000001318. PMID:
39498846. Review. ˍ
Yan S, Zhu X, Xiao Y.
CD70-targeted
CAR-T/NK therapy: Rationale, advances, and future directions.
Transl
Oncol. 2025 Oct 2;62:102555. doi:
10.1016/j.tranon.2025.102555. PMID:
41043320. Review.
ˍ
Bria J, Filardo A, Di Vito A, Della Torre A, Lavano A, Coscarella
I, Chiarella E, Procopio E, Egiziano MT, Longo P, La Torre
D.
Recurrent Limitations of CAR-T
Therapy in Gliomas: Evidence from Preclinical and Phase I Clinical
Studies.
Int
J Mol Sci. 2025 Nov 26;26(23):11435. doi:
10.3390/ijms262311435. PMID:
41373591. Review. ˍ
Li
X, Shang X, Liu J, Zhang Y, Jia X, Li H, Wang Y, Gao J, Ma X,
Zhang X, Rong X, Gan W, Zhang Y, Chen J, Wang L, Bao Z, He L, Yan
X, Liu Y, Shao J, Xiao Z, Wang Z, Zhu H, Wang Z, Wu Y, Huang Y.
Intrathecal
CRISPR-edited allogeneic IL-13Rα2 CAR T Cells for recurrent
high-grade Glioma: preclinical characterization and phase I trial.
Nat
Commun.
2026 Jan 6. doi:
10.1038/s41467-025-68112-6. PMID:
41495049. Interventional study. ˍ